TCR2 Therapeutics Inc. Debt to Equity Ratio 2019-2023 | TCRR
Current and historical debt to equity ratio values for TCR2 Therapeutics Inc. (TCRR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. TCR2 Therapeutics Inc. debt/equity for the three months ending March 31, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-03-31 | $0.05B | $0.10B | 0.50 |
| 2022-12-31 | $0.07B | $0.14B | 0.48 |
| 2022-09-30 | $0.07B | $0.20B | 0.38 |
| 2022-06-30 | $0.08B | $0.23B | 0.36 |
| 2022-03-31 | $0.07B | $0.26B | 0.27 |
| 2021-12-31 | $0.04B | $0.28B | 0.15 |
| 2021-09-30 | $0.04B | $0.31B | 0.13 |
| 2021-06-30 | $0.04B | $0.33B | 0.12 |
| 2021-03-31 | $0.05B | $0.35B | 0.13 |
| 2020-12-31 | $0.01B | $0.24B | 0.04 |
| 2020-09-30 | $0.01B | $0.25B | 0.03 |
| 2020-06-30 | $0.01B | $0.13B | 0.05 |
| 2020-03-31 | $0.01B | $0.15B | 0.05 |
| 2019-12-31 | $0.01B | $0.16B | 0.05 |
| 2019-09-30 | $0.01B | $0.17B | 0.05 |
| 2019-06-30 | $0.01B | $0.18B | 0.04 |
| 2019-03-31 | $0.01B | $0.19B | 0.03 |
| 2018-12-31 | $0.01B | $0.12B | 0.05 |
| 2018-09-30 | $0.00B | 0.00 | |
| 2018-06-30 | $0.00B | 0.00 | |
| 2018-03-31 | $0.00B | 0.00 | |
